ATHOS KG Finds Home for Biosimilars Bet
Posted on 07/04/2022
Biosimilars are follow-on versions of biopharmaceuticals, for which exclusivity has expired. They are approved via stringent regulatory pathways in highly regulated markets based on proven similarity of the biosimilar with the originator biopharmaceutical reference product. ATHOS KG is the family office of the Strüngmann family. The Strüngmann family are the founders of the pharmaceutical company…
